A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.
Sandborn
William J
WJ
The Clinical Trials Task Force of the International Organization of Inflammatory Bowel Disease. sandborn.william@mayo.edu
Feagan
Brian G
BG
Hanauer
Stephen B
SB
Lochs
Herbert
H
Löfberg
Robert
R
Modigliani
Robert
R
Present
Daniel H
DH
Rutgeerts
Paul
P
Schölmerich
Jurgen
J
Stange
Eduard F
EF
Sutherland
Lloyd R
LR
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003424:Crohn Disease / Q000145:classification / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012720:Severity of Illness Index; D013256:Steroids
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D013256:Steroids